AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3295548 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation
Number of subjects: 174
Study 3295548 — intervention group
Group type: COMPARATOR
Intervention: Control (therapy without photocoagulation)
Number of subjects: 174
Study 29405252 — intervention group
Group type: EXPERIMENTAL
Intervention: No supplementation and no blood test on postoperative day 1 (intervention group)
Number of subjects: 146
Study 29405252 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up (measurement of calcium and parathyroid hormone on postoperative day 1 and systematic supplementation with calcium and vitamin D; control group)
Number of subjects: 146
Study 29405252 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with no well perfused parathyroid gland identified by angiography (excluded patients)
Number of subjects: 146
Study 27271190 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 0
Study 27271190 — intervention group
Group type: EXPERIMENTAL
Intervention: Large initial weight loss
Number of subjects: 0
Study 27271190 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance of weight loss
Number of subjects: 0
Study 27271190 — intervention group
Group type: EXPERIMENTAL
Intervention: Full regain of weight after large initial weight loss
Number of subjects: 0
Study 27271190 — intervention group
Group type: COMPARATOR
Intervention: No weight loss
Number of subjects: 0
Study 24911369 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant regimen (ondansetron and dexamethasone plus aprepitant)
Number of subjects: 848
Study 24911369 — intervention group
Group type: COMPARATOR
Intervention: Control (ondansetron and dexamethasone)
Number of subjects: 848
Study 21987530 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist counseling
Number of subjects: 67
Study 21987530 — intervention group
Group type: COMPARATOR
Intervention: Printed materials (Control)
Number of subjects: 67
Study 20482322 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (20 microg/day)
Number of subjects: 868
Study 20482322 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/day)
Number of subjects: 868
Study 20482322 — intervention group
Group type: COMPARATOR
Intervention: No active treatment
Number of subjects: 868
Study 18572079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 185
Study 18572079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 16097980 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Misgav-Ladach (MML) technique
Number of subjects: 162
Study 16097980 — intervention group
Group type: COMPARATOR
Intervention: Pfannenstiel-Kerr technique
Number of subjects: 162
Study 12626201 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (280 mg in pump prime)
Number of subjects: 30
Study 12626201 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 12903826 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (2 mg/kg)
Number of subjects: 35
Study 12903826 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (30 microg/kg)
Number of subjects: 35
Study 12903826 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 7862470 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice (4 ounces)
Number of subjects: 28
Study 7862470 — intervention group
Group type: COMPARATOR
Intervention: White grape juice (8 ounces)
Number of subjects: 28
Study 7862470 — intervention group
Group type: EXPERIMENTAL
Intervention: Both juices
Number of subjects: 28
Study 8465822 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-polymer solution
Number of subjects: 8
Study 3079994 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched chain‐enriched amino acid solutions (valine-enriched)
Number of subjects: 37
Study 3079994 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched chain‐enriched amino acid solutions (leucine-enriched)
Number of subjects: 37
Study 3079994 — intervention group
Group type: COMPARATOR
Intervention: Standard amino acid solution
Number of subjects: 37
Study 30336598 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron Treatment Group (ITG) - 325mg/d of ferrous sulphate for 11 weeks
Number of subjects: 22
Study 30336598 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 22
Study 30336598 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron Treatment Group (ITG)
Number of subjects: 22
Study 27352777 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with guar gum (2.5g)
Number of subjects: 30
Study 27352777 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with alginate (2.5g)
Number of subjects: 30
Study 27352777 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with carrageenan (2.5g)
Number of subjects: 30
Study 27352777 — intervention group
Group type: COMPARATOR
Intervention: Milk (2% M.F.) - Control
Number of subjects: 30
Study 27132446 — intervention group
Group type: EXPERIMENTAL
Intervention: Auscultation
Number of subjects: 60
Study 27132446 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial pressure of carbon dioxide in end-expiration (P(ET)CO2)
Number of subjects: 60
Study 27132446 — intervention group
Group type: EXPERIMENTAL
Intervention: Transillumination technique
Number of subjects: 60
Study 23528388 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (5 days/week, 2 sessions/day for 21 days, 15 min/session)
Number of subjects: 60
Study 23528388 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation program without mirror therapy
Number of subjects: 60
Study 21627403 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose parenteral polyoestradiol phosphate (PEP) 240 mg i.m. twice a month for 2 months and thereafter monthly
Number of subjects: 915
Study 21627403 — intervention group
Group type: COMPARATOR
Intervention: Combined androgen deprivation (CAD) with flutamide (Eulexin®) 250 mg per os three times daily and triptorelin (Decapeptyl®) 3.75 mg i.m. per month or bilateral orchidectomy
Number of subjects: 915
Study 18757238 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg aspirin (ASA) and 200 mg extended-release dipyridamole (ER-DP) twice a day
Number of subjects: 20332
Study 18757238 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg clopidogrel once a day
Number of subjects: 20332
Study 18757238 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg telmisartan once per day
Number of subjects: 20332
Study 18757238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20332
Study 16825509 — intervention group
Group type: EXPERIMENTAL
Intervention: 16S rDNA polymerase chain reaction (PCR) assay
Number of subjects: 1233
Study 16825509 — intervention group
Group type: COMPARATOR
Intervention: Blood culturing
Number of subjects: 1233
Study 12908135 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation strategies
Number of subjects: 0
Study 12908135 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 0
Study 12908135 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum and 5-fluorouracil drug combinations
Number of subjects: 0
Study 12908135 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxane-based regimens
Number of subjects: 0
Study 12908135 — intervention group
Group type: EXPERIMENTAL
Intervention: New biologic agents in combined modality treatment schemes
Number of subjects: 0
Study 11127445 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose of enalapril (mean dose achieved 17.9 mg/day)
Number of subjects: 248
Study 11127445 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of enalapril (mean dose achieved 42 mg/day)
Number of subjects: 248
Study 7746415 — intervention group
Group type: EXPERIMENTAL
Intervention: linopirdine
Number of subjects: 35
Study 2154428 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (three regimens including a single oral dose)
Number of subjects: 168
Study 2154428 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline (standard treatment)
Number of subjects: 168
Study 2154428 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 168
Study 7470437 — intervention group
Group type: EXPERIMENTAL
Intervention: 13% protein-energy in three meals/d for the first week
Number of subjects: 38
Study 7470437 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% protein-energy as three meals/d
Number of subjects: 38
Study 7470437 — intervention group
Group type: EXPERIMENTAL
Intervention: 13% protein-energy as five or one meal/d
Number of subjects: 38
Study 7470437 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% protein-energy as five meals/d or 10% protein-energy as one meal/d
Number of subjects: 38
Study 7470437 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic diet with lower-protein concentration fed as fewer meals
Number of subjects: 38
Study 31875053 — intervention group
Group type: EXPERIMENTAL
Intervention: LAV% of larger bullae
Number of subjects: 99
Study 31875053 — intervention group
Group type: EXPERIMENTAL
Intervention: Two ED % of scales and location-dependent variables
Number of subjects: 99
Study 28008750 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mix (Lactobacillus acidophilus and casei; Lactococcus lactis; Bifidobacterium bifidum and lactis; 2 × 10^10 colony‐forming units/day)
Number of subjects: 43
Study 28008750 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mix
Number of subjects: 43
Study 26218852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (20 mg, single oral dose)
Number of subjects: 29
Study 26218852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 23727103 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (Mi) + Morphine (Mo)
Number of subjects: 1763
Study 23727103 — intervention group
Group type: COMPARATOR
Intervention: Morphine (Mo) alone
Number of subjects: 1763
Study 20049561 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron (0.25 mg i.v.)
Number of subjects: 144
Study 20049561 — intervention group
Group type: COMPARATOR
Intervention: Granisetron (3 mg i.v.)
Number of subjects: 144
Study 19288149 — intervention group
Group type: EXPERIMENTAL
Intervention: Sea buckthorn berries (SBB), 28 g daily for 3 months
Number of subjects: 229
Study 19288149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study 19288149 — intervention group
Group type: EXPERIMENTAL
Intervention: Sea buckthorn berries (SBB)
Number of subjects: 229
Study 16979292 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cTBS stimulation
Number of subjects: 20
Study 16979292 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (placebo)
Number of subjects: 20
Study 15599835 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone infusion for 48 to 72 hours
Number of subjects: 949
Study 15599835 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion for 48 to 72 hours
Number of subjects: 949
Study 11056773 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 100 micrograms/kg/min
Number of subjects: 36
Study 11056773 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 200 micrograms/kg/min
Number of subjects: 36
Study 11056773 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 36
Study 9300324 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 38
Study 9300324 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 38
Study 9300324 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amlodipine and hydrochlorothiazide
Number of subjects: 38
Study 9300324 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine or Hydrochlorothiazide or both
Number of subjects: 38
Study 7944426 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative intrahepatic arterial infusion with Farmorubicin and 5‐FU (i.a group)
Number of subjects: 17
Study 7944426 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chemotherapy)
Number of subjects: 17
Study 2976670 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (3 mg/kg oral and 1 mg/kg i.v.)
Number of subjects: 6
Study 2976670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30100052 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-moderate epinephrine doses
Number of subjects: 24
Study 28185994 — intervention group
Group type: EXPERIMENTAL
Intervention: MI intervention to patients only
Number of subjects: 240
Study 28185994 — intervention group
Group type: EXPERIMENTAL
Intervention: MI intervention to patients and caregivers
Number of subjects: 240
Study 28185994 — intervention group
Group type: COMPARATOR
Intervention: Standard of care to patients and caregivers
Number of subjects: 240
Study 25512674 — intervention group
Group type: EXPERIMENTAL
Intervention: Team captain‐led and poster STI screening promotion
Number of subjects: 153
Study 25512674 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual health adviser‐led and poster STI screening promotion
Number of subjects: 153
Study 25512674 — intervention group
Group type: COMPARATOR
Intervention: Poster‐only STI screening promotion
Number of subjects: 153
Study 23108378 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises (PFME)
Number of subjects: 102
Study 23108378 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PFME)
Number of subjects: 102
Study 21962963 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary management
Number of subjects: 57
Study 21962963 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 57
Study 21962963 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (dietary management and physical exercise)
Number of subjects: 57
Study 21962963 — intervention group
Group type: COMPARATOR
Intervention: All interventions (dietary management, physical exercise, or both)
Number of subjects: 57
Study 21962963 — intervention group
Group type: COMPARATOR
Intervention: Follow-up after 2.8 years
Number of subjects: 57
Study 18251595 — intervention group
Group type: EXPERIMENTAL
Intervention: Pendulum appliance supported with a K‐loop buccally
Number of subjects: 30
Study 18251595 — intervention group
Group type: COMPARATOR
Intervention: Cervical headgear
Number of subjects: 30
Study 16356485 — intervention group
Group type: EXPERIMENTAL
Intervention: CI-1034 (50mg BID)
Number of subjects: 0
Study 16356485 — intervention group
Group type: EXPERIMENTAL
Intervention: CI-1034
Number of subjects: 0
Study 15062137 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy with supplemental external beam radiation therapy (XRT)
Number of subjects: 213
Study 15062137 — intervention group
Group type: COMPARATOR
Intervention: Brachytherapy without supplemental external beam radiation therapy (XRT)
Number of subjects: 213
Study 11004287 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol GFS 0.5%
Number of subjects: 241
Study 11004287 — intervention group
Group type: COMPARATOR
Intervention: Timoptic XE 0.5%
Number of subjects: 241
Study 8645023 — intervention group
Group type: EXPERIMENTAL
Intervention: HCFU + DP
Number of subjects: 653
Study 8645023 — intervention group
Group type: COMPARATOR
Intervention: HCFU
Number of subjects: 653
Study 1333960 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin (4 micrograms kg‐1 bw, two high dose intravenous bolus injections at a 30 min interval, n = 6)
Number of subjects: 12
Study 1333960 — intervention group
Group type: COMPARATOR
Intervention: ANF(99‐126) (4 micrograms kg‐1 bw, same dosing as Urodilatin, n = 6)
Number of subjects: 12
Study 3870892 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care participants attending clinic
Number of subjects: 0
Study 3870892 — intervention group
Group type: EXPERIMENTAL
Intervention: HDFP participants
Number of subjects: 0
Study 3870892 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reporting side effects
Number of subjects: 0
Study 30915366 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid injection combined with miniscalpel-needle (MSN) release
Number of subjects: 51
Study 30915366 — intervention group
Group type: COMPARATOR
Intervention: Steroid injection alone
Number of subjects: 51
Study 29355920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-mode survey designs (mail/web or web/mail)
Number of subjects: 275
Study 29355920 — intervention group
Group type: COMPARATOR
Intervention: Mail-only
Number of subjects: 275
Study 29355920 — intervention group
Group type: COMPARATOR
Intervention: Web/mail
Number of subjects: 275
Study 29355920 — intervention group
Group type: COMPARATOR
Intervention: Single-mode designs (mail-only/web-only)
Number of subjects: 275
Study 26824795 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-29 mmHg compression stocking (Stocking A)
Number of subjects: 80
Study 26824795 — intervention group
Group type: COMPARATOR
Intervention: 8-16 mmHg compression stocking (Stocking B)
Number of subjects: 80
Study 25040756 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg·kg(‐1) 6-hourly for up to 5 days
Number of subjects: 71
Study 25040756 — intervention group
Group type: COMPARATOR
Intervention: Placebo 6-hourly for up to 5 days
Number of subjects: 71
Study 25040756 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 71
Study 25040756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 22147076 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant temozolomide (6 cycles)
Number of subjects: 0
Study 20025149 — intervention group
Group type: EXPERIMENTAL
Intervention: NG‐nitro‐L‐arginine‐methyl‐ester (1 mg x kg(‐1))
Number of subjects: 12
Study 20025149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 17998767 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous balloon mitral valvuloplasty (PBMV)
Number of subjects: 60
Study 17998767 — intervention group
Group type: COMPARATOR
Intervention: Control group (35 age- and gender-matched healthy volunteers)
Number of subjects: 60
Study 15889234 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (15-45 mg/day)
Number of subjects: 1269
Study 15889234 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide (80-320 mg/day)
Number of subjects: 1269
Study 15889234 — intervention group
Group type: COMPARATOR
Intervention: Metformin (850-2,550 mg/day)
Number of subjects: 1269
Study 12485118 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole 60 mg once a day (qd)
Number of subjects: 67
Study 12485118 — intervention group
Group type: COMPARATOR
Intervention: lansoprazole 30 mg twice a day (bid)
Number of subjects: 67
Study 12485118 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB positive group
Number of subjects: 67
Study 12485118 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB negative group
Number of subjects: 67
Study 12485118 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB duration for H. pylori eradication group
Number of subjects: 67
Study 12485118 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB duration for H. pylori persistence group
Number of subjects: 67
Study 12485118 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication group
Number of subjects: 67
Study 12485118 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori persistence group
Number of subjects: 67
Study 9787889 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg daily
Number of subjects: 36
Study 9787889 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 7649971 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose range nefazodone (100-600 mg/day)
Number of subjects: 240
Study 7649971 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2-6 capsules per day)
Number of subjects: 240
Study 7649971 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose range nefazodone (50-300 mg/day)
Number of subjects: 240
Study 2524219 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant replacement
Number of subjects: 0
Study 2524219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2524219 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant replacement and placebo
Number of subjects: 0
Study 1221110 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.67 g/kg body weight) ingested at 0700
Number of subjects: 6
Study 1221110 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.67 g/kg body weight) ingested at 1100
Number of subjects: 6
Study 1221110 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.67 g/kg body weight) ingested at 1900
Number of subjects: 6
Study 1221110 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.67 g/kg body weight) ingested at 2300
Number of subjects: 6
Study 31942688 — intervention group
Group type: EXPERIMENTAL
Intervention: Banded OAGB
Number of subjects: 33
Study 31942688 — intervention group
Group type: COMPARATOR
Intervention: Non-banded OAGB
Number of subjects: 33
Study 31242001 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Engagement and Planning (CEP)
Number of subjects: 1246
Study 31242001 — intervention group
Group type: COMPARATOR
Intervention: Resources for Services (RS)
Number of subjects: 1246
Study 28104470 — intervention group
Group type: EXPERIMENTAL
Intervention: CONNECT intervention (oncology nurse-led care management approach)
Number of subjects: 0
Study 28104470 — intervention group
Group type: COMPARATOR
Intervention: Standard oncology care
Number of subjects: 0
Study 25772437 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes
Number of subjects: 152
Study 25772437 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 152
Study 25772437 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana
Number of subjects: 152
Study 25772437 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine
Number of subjects: 152
Study 23026869 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 101
Study 23026869 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 101
Study 23026869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 21891985 — intervention group
Group type: EXPERIMENTAL
Intervention: Rinse containing miconazole nitrate (COFRM)
Number of subjects: 0
Study 21891985 — intervention group
Group type: COMPARATOR
Intervention: Rinse without miconazole nitrate (COFR)
Number of subjects: 0
Study 19251144 — intervention group
Group type: EXPERIMENTAL
Intervention: SofPort Advanced Optics IOL with no aberration (no‐aberration IOL group)
Number of subjects: 0